154 related articles for article (PubMed ID: 12476961)
1. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
Liu G; Trevillyan JM
Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
[TBL] [Abstract][Full Text] [Related]
2. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
[TBL] [Abstract][Full Text] [Related]
3. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
Nandi S; Saxena M
Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
[TBL] [Abstract][Full Text] [Related]
4. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
5. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
[TBL] [Abstract][Full Text] [Related]
6. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
Prabhakar PK; Sivakumar PM
Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
[TBL] [Abstract][Full Text] [Related]
7. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
[TBL] [Abstract][Full Text] [Related]
8. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.
Teimouri M; Hosseini H; ArabSadeghabadi Z; Babaei-Khorzoughi R; Gorgani-Firuzjaee S; Meshkani R
J Physiol Biochem; 2022 May; 78(2):307-322. PubMed ID: 34988903
[TBL] [Abstract][Full Text] [Related]
9. Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update.
Liu Z; Gao H; Zhao Z; Huang M; Wang S; Zhan J
Biomed Pharmacother; 2023 Jan; 157():113990. PubMed ID: 36459712
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
[No Abstract] [Full Text] [Related]
11. A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics.
Agrawal N; Dhakrey P; Pathak S
Chem Biol Drug Des; 2023 Oct; 102(4):921-938. PubMed ID: 37232059
[TBL] [Abstract][Full Text] [Related]
12. The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance.
Abdelsalam SS; Korashy HM; Zeidan A; Agouni A
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31319588
[TBL] [Abstract][Full Text] [Related]
13. Discovery and biological evaluation of novel dual PTP1B and ACP1 inhibitors for the treatment of insulin resistance.
Feng B; Zhang J; Liu Z; Xu Y; Hu H
Bioorg Med Chem; 2024 Jan; 97():117545. PubMed ID: 38070352
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of cold and hot tea extracts on tyrosine phosphatases regulating insulin receptor activity: a focus on PTP1B and LMW-PTP.
Genovese M; Luti S; Pardella E; Vivoli-Vega M; Pazzagli L; Parri M; Caselli A; Cirri P; Paoli P
Eur J Nutr; 2022 Jun; 61(4):1905-1918. PubMed ID: 35066640
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine phosphatase 1B in metabolic diseases and drug development.
Delibegović M; Dall'Angelo S; Dekeryte R
Nat Rev Endocrinol; 2024 Jun; 20(6):366-378. PubMed ID: 38519567
[TBL] [Abstract][Full Text] [Related]
16. Nepetin Acts as a Multi-Targeting Inhibitor of Protein Tyrosine Phosphatases Relevant to Insulin Resistance.
Yoon SY; Ahn D; Kim JK; Seo SO; Chung SJ
Chem Biodivers; 2022 Jan; 19(1):e202100600. PubMed ID: 34725898
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Orally Bioavailable Purine-Based Inhibitors of the Low-Molecular-Weight Protein Tyrosine Phosphatase.
Stanford SM; Diaz MA; Ardecky RJ; Zou J; Roosild T; Holmes ZJ; Nguyen TP; Hedrick MP; Rodiles S; Guan A; Grotegut S; Santelli E; Chung TDY; Jackson MR; Bottini N; Pinkerton AB
J Med Chem; 2021 May; 64(9):5645-5653. PubMed ID: 33914534
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides.
Luo J; Zheng M; Jiang B; Li C; Guo S; Wang L; Li X; Yu R; Shi D
Br J Pharmacol; 2020 Oct; 177(19):4464-4480. PubMed ID: 32663313
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in PTP1B signaling in metabolism and cancer.
Villamar-Cruz O; Loza-Mejía MA; Arias-Romero LE; Camacho-Arroyo I
Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34726241
[TBL] [Abstract][Full Text] [Related]
20. Targeted Inhibition of Protein Tyrosine Phosphatase 1B by Viscosol Ameliorates Type 2 Diabetes Pathophysiology and Histology in Diabetic Mouse Model.
Sohail A; Fayyaz H; Muneer H; Raza I; Ikram M; Uddin Z; Gul S; Almohaimeed HM; Alsharif I; Alaryani FS; Ullah I
Biomed Res Int; 2022; 2022():2323078. PubMed ID: 36875821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
